Background. Several studies have demonstrated the presence of the Borrelia burgdorferi (Bb) genome in the myocardium of patients with dilated cardiomyopathy (DCM). To further support a causal relationship between the presence of Bb in the heart muscle and the development of DCM, demonstration of the absence of Bb in the myocardium of subjects with normal left ventricular (LV) systolic function is needed. Aim. To determine the prevalence of Bb by polymerase chain reaction (PCR) and electron microscopy (EM) in individuals with normal LV systolic function and no history suggestive of myocarditis. Methods. We investigated 50 patients (67 ± 9 years, 15 women) with normal LV ejection fraction (EF) ≥ 50% undergoing cardiac surgery. During surgery, four samples from the right atrial appendage were obtained and subsequently examined by PCR and EM for the presence of Bb, and by immunohistochemistry to detect inflammatory cells. Serological testing of antibodies against Bb was also performed. 
INTRODUCTION
Dilated cardiomyopathy (DCM) is a term used for dilatation and systolic dysfunction of the left ventricle (LV) (ref. 1 ). Dilated cardiomypathy may develop as a consequence of acute myocarditis 2 . Myocarditis and DCM are most frequently associated with viral infection of the myocardium 3, 4 ; however, they may be also triggered by non-viral infectious agents. Within the endemic region of Central Europe there is increasing evidence that Borrelia burgdorferi (Bb) may be associated with the development of DCM (ref. [5] [6] [7] ). To further support a causal relationship between the presence of Bb in the heart muscle and the development of DCM, demonstration of the absence of Bb in the myocardium of subjects with normal left ventricular (LV) systolic function is necessary. In this study we aimed to determine the prevalence of Bb by polymerase chain reaction (PCR) and electron microscopy (EM) in individuals with normal LV systolic function and no history suggestive of myocarditis.
MATERIAL AND METHODS
The study was prospectively conducted between January 2013 and September 2014. Myocardial samples from 50 adult subjects (67 ± 9 years; 15 women) with LV ejection fraction ≥ 50% undergoing myocardial revascularization and/or heart valve surgery were examined. None of the subjects had a previous history of myocarditis or a recent febrile illness, and all had normal plasma levels of CRP and white blood cells. During surgery four samples of right atrial appendage tissue were obtained. Two tissue samples were subsequently examined by PCR and EM for the presence of Bb, and two samples were examined by immunohistochemistry for inflammatory cells. Blood samples obtained from each subject were analyzed serologically for the presence of antibodies against Bb.
The study design was approved by the local ethics committee and informed written consent was obtained from all subjects prior to participating in this study. The investigation conforms to the principles outlined in the current Declaration of Helsinki.
Laboratory analysis
Four myocardial samples of right atrial appendage were taken from each study subject.
The first tissue sample was immediately placed in physiologic saline and transported to a dedicated electron microscopy laboratory where it was evaluated for the presence of Bb. The sample of cardiac tissue (1 -2 mm 3 ) was frozen and thawed three times. Subsequently, it was dissected in distilled water (2 mL) and stored for 20 min to lyse at room temperature. Thereafter, low speed centrifugation (665 g for 5 min) of the samples was performed to remove cell debris. The supernatants were centrifuged (11180 g for 60 min at 4 o C) and sediments were re-suspended in a small amount of distilled water. Suspensions were applied onto 2400-mesh copper grids coated with 1% polyvinyl formal (Formvar) and reinforced with a carbon layer. Two grids were used for each suspension; one was negatively stained with 2% ammonium molybdate and the other was stained with 2% aqueous uranyl acetate. Since aqueous uranyl acetate and ammonium molybdate have different staining properties, both stains were applied in parallel to all samples. Both grids were examined for Bb under a JEOL JEM-100 CX II electron microscope at a magnification of 30000x. The sensitivity of trasmission electron microscopy depends on the concentration of Bb particles in the examined tissue sample. The detection limit is usually 10 6 / mL if no concentration method is used and can be decreased to 5x10 4 / mL if concentration method is applied 8 . The second myocardial sample was immediately placed in physiological saline and transported to a dedicated laboratory where it was analysed by PCR for the presence of the Bb genome. A DNeasy Blood & Tissue Kit (Qiagen® GmbH, Hilden, Germany) was used for purification of total DNA from the myocardial tissue samples. Starting from ~ 25 mg of tissue, the protocol was followed for purification of total DNA from tissue according to the manufacturer's instructions. DNA was eluted in a final volume of 200 μL of AE buffer. Nested PCR using ospA primers (coding for the outer surface protein A) (ref. 9 ) and a real time PCR targeting 16S rRNA gene (GeneProof Borrelia burgdorferi kit, GeneProof, Czech Republic) were performed in parallel. The analytical sensitivity of the GeneProof Borrelia burgdorferi kit is 0.572 copies/ μL (P = 0.05 . We included a positive control of genomic DNA of Borrelia garinii strain 192M (ref. 10 ), a negative control of amplification (H 2 O), and a negative control of isolation (no sample) in each run.
The remaining two samples of myocardial tissue were placed in 10% formalin solution and transported to a dedicated pathological laboratory where they were subjected to immunohistochemical analysis. Immunohistochemical analysis comprised of staining for leukocyte common antigen-positive cells (LCA+), CD3+ (T-lymphocytes) and CD68+ (macrophages) immunocompetent cells, as well as for HLA-DR positivity. Myocardial inflammation was defined as the presence of ≥14 leucocytes/mm 2 including ≥7 lymphocytes/mm 2 (ref.
11
). The enhanced expression of HLA DR (class 2 or 3) was supportive for a diagnosis of myocardial inflammation 11 .
Statistical Analysis
Data were expressed as means ± standard deviation or as a number and percentage of subjects, as appropriate. Statistical analysis was performed with JMP 5.1 statistical software (SAS Institute Inc., Cary, NC, USA).
RESULTS
The majority of study subjects (33 individuals, 66%) underwent only surgical myocardial revascularization. Isolated heart valve surgery was performed in 12 (24%) subjects and a combined surgical procedure (coronary artery bypass grafting together with heart valve surgery) was performed in 5 (10%) patients.
Using PCR and electron microscopy, no Bb was found in the myocardium of any of the study subjects. Immunohistochemical signs of myocardial inflammation were detected in 2 (4%) individuals (Fig.1) . Enhanced HLA-DR expression was detected in just 1 of these 2 patients.
Serological analysis by ELISA demonstrated IgM antibodies against Bb in 2 subjects (4%) and IgG antibodies in 6 individuals (12%); WB revealed IgM as well as IgG positivity in 7 patients (14%). WB confirmed positive results gained by ELISA analysis in all subjects and found an additional 5 subjects with IgM antibodies positivity and 1 individual with IgG antibodies positivity.
DISCUSSION
The development of DCM is a frequently reported sequel to viral myocarditis. However, nonviral infectious agents are also involved in DCM pathogenesis. There is limited but increasing evidence that Bb infection can be associated with the development of DCM. Borrelia burgdorferi was first cultured from the myocardium of a 54-year-old man with long-standing DCM in 1990 (ref. 12 ). On the other hand, other authors investigating myocardial samples obtained from patients with endstage DCM using PCR were unable to detect Bb in any of these subjects 13, 14 . Moreover, in endomycardial samples (EMB) from patients with suspected inflammatory heart disease (including individuals with DCM) and Bb positive serology, the Bb genome was not revealed by PCR in any subject 15 . However, in regions highly endemic for Lyme disease such as the Czech Republic, Bb has been repeatedly detected in the myocardium of patients with recent-onset unexplained DCM. In a pilot study from our centre, we have reported a 21% prevalence of Bb in EMB specimens obtained from 39 patients with recent-onset DCM (ref. 5 ). Similar findings were subsequently published by other Czech authors 6 . Furthermore, in our very recently published study, the Bb genome was detected in 22 (20%) out of 110 patients with recent-onset unexplained DCM (ref. 7 ). All Bb-positive patients were treated with intravenous ceftriaxone for 21 days in addition to conventional heart failure medication and showed significant improvement of LV ejection fraction and heart failure symptoms at one-year follow-up.
In the present study, Bb was not detected in the myocardial samples of any subject undergoing cardiac surgery with preserved LV systolic function, using PCR and EM. The absence of Bb in these individuals further supports a causal relationship between the presence of Bb in the heart muscle and the development of DCM.
Serological tests for antibodies to Bb have been the mainstay of laboratory diagnosis of Lyme disease 16 . However, Lyme borreliosis is primarily a clinical diagnosis and serological analysis is thus rather supportive in the diagnostic process 17 . In our study, ELISA detected IgM antibodies against Bb in 2 subjects and IgG antibodies in 6 individuals, while WB revealed IgM as well as IgG positivity in 7 patients. None of these patients had a history of Lyme disease or clinical signs suspicious of Lyme disease. It is well known that decreased specificity leading to false positivity of these serological assays could be caused by factors directly linked with the assays, such as the use of too low cut-off levels or the presence of cross-reacting antibodies 18 . Other factors may influence these serological methods indirectly, such as oligoclonal stimulation seen in some viral as well as non-viral infections. Moreover, in regions that are highly endemic for Lyme disease like the Czech Republic, high sero-prevalence of specific antibodies is present in the general population and the relevance to clinical disease is therefore questionable. In recent study by Kodym et al. (ref. 19 ) sera of 100 healthy blood donors with negative history of Lyme disease were examined and serological examination revealed seropositivity in 29% of individuals. In more detail, isolated IgM antibodies against Bb were detected in 7% of the subjects and IgG antibodies in 17% of the healthy volunteers. Both IgM and IgG antibodies were positive in 5% of the blood donors. Based on our findings and results from other studies we think that isolated positivity of Bb antibodies in subjects with no clinical history and signs of Lyme disease is of limited clinical value. Finally, in our subjects with preserved LV systolic function undergoing cardiac surgery immunohistochemical signs of myocardial inflammation were extremely rare. Two subjects met the current criteria for myocardial inflammation 20 but only one of these two individuals exhibited noncellular HLA-DR positivity, supporting the diagnosis of myocardial inflammation. These findings reiterate those seen in published studies and confirm the utility of the immunohistochemical criteria in the diagnosis of inflammatory DCM (ref. 11, 21 ).
CONCLUSIONS
The absence of Bb, as assessed by both PCR and EM, in the myocardium of subjects with normal LV systolic function and no history suggestive of myocarditis, supports the theory of causal relationship between Bb infection and DCM development. 
